Longtime collaborators Phoenix Nuclear Labs and Shine Medical Technologies have entered into a supply and development agreement. Phoenix has agreed to provide neutron generators for use by Shine in its planned molybdenum-99 manufacturing facility. Shine will provide Phoenix support to improve its technology.
Nordion is set to receive its first batch of molybdenum-99 isotopes from Russian firm Isotope. The shipment, of which Nordion is not specifying the amount, will "help alleviate the impact of the planned NRU reactor shutdown currently intended for mid-May 2011," Nordion said.
The U.S. Department of Energy's National Nuclear Security Administration has awarded NTP Radioisotopes, a unit of the Nuclear Energy Corporation of South Africa, a contract worth $25 million for the production of the medical isotope molybdenum-99 using low-enriched uranium. NTP Radioisotopes will be working with the Australian Nuclear Science and Technology Organisation in this initiative.
More than 50 hospitals, nursing homes and other health care organizations in New Jersey are collaborating to curb hospital readmissions related to heart failure in the state. The initiative includes data sharing as well as informational sessions for patients and providers on the factors leading to heart failure readmissions and how to reduce them.
Elliott Jacobson, chief of staff for Delaware Insurance Commissioner Karen Weldin Stewart, said Blue Cross Blue Shield of Delaware will no longer be requiring doctors to get pre-authorization for nuclear stress tests. The group, however, has not yet released information relating to the expected changes to its pre-authorization program.